HUE041277T2 - Vakcina terápia - Google Patents
Vakcina terápiaInfo
- Publication number
- HUE041277T2 HUE041277T2 HUE12772616A HUE12772616A HUE041277T2 HU E041277 T2 HUE041277 T2 HU E041277T2 HU E12772616 A HUE12772616 A HU E12772616A HU E12772616 A HUE12772616 A HU E12772616A HU E041277 T2 HUE041277 T2 HU E041277T2
- Authority
- HU
- Hungary
- Prior art keywords
- vaccine therapy
- vaccine
- therapy
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2011/052992 | 2011-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE041277T2 true HUE041277T2 (hu) | 2019-05-28 |
Family
ID=47018510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE12772616A HUE041277T2 (hu) | 2011-09-23 | 2012-09-21 | Vakcina terápia |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20240270829A1 (hu) |
| EP (1) | EP2758071B1 (hu) |
| JP (1) | JP6110861B2 (hu) |
| KR (3) | KR20160005380A (hu) |
| CN (2) | CN109847058A (hu) |
| AU (1) | AU2012312126B2 (hu) |
| BR (1) | BR112014006871A2 (hu) |
| CA (1) | CA2811188C (hu) |
| DK (1) | DK2758071T3 (hu) |
| EA (1) | EA032494B1 (hu) |
| ES (1) | ES2712951T3 (hu) |
| HU (1) | HUE041277T2 (hu) |
| IL (1) | IL231564A0 (hu) |
| MX (1) | MX350928B (hu) |
| MY (1) | MY169574A (hu) |
| PH (1) | PH12014500657A1 (hu) |
| PL (1) | PL2758071T3 (hu) |
| PT (1) | PT2758071T (hu) |
| SG (1) | SG11201400795UA (hu) |
| SI (1) | SI2758071T1 (hu) |
| TR (1) | TR201901846T4 (hu) |
| WO (1) | WO2013044147A1 (hu) |
| ZA (1) | ZA201402071B (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201701181XA (en) | 2012-08-16 | 2017-04-27 | Ipierian Inc | Methods of treating a tauopathy |
| US8980270B2 (en) | 2013-01-18 | 2015-03-17 | Ipierian, Inc. | Methods of treating a tauopathy |
| EP3104870A4 (en) | 2014-02-14 | 2017-09-13 | Ipierian, Inc. | Tau peptides, anti-tau antibodies, and methods of use thereof |
| WO2020097155A1 (en) | 2018-11-06 | 2020-05-14 | Alsatech, Inc. | Cell-based gene therapy for neurodegenerative diseases |
| JP2022533422A (ja) | 2019-05-21 | 2022-07-22 | エイシー イミューン ソシエテ アノニム | 抗ａベータワクチン療法 |
| WO2024156912A1 (en) | 2023-01-26 | 2024-08-02 | Ac Immune Sa | Anti-abeta vaccine therapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9811401A (pt) | 1997-08-28 | 2000-08-29 | Ajay North America E Som Iodo | Processos para proteger uma substância agrìcola contra pestes que são nocivas para a substância agrìcola e para a proteção de uma substãncia agrìcola, e, composição protetora para substâncias agrìcolas |
| JP2006525226A (ja) | 2002-12-24 | 2006-11-09 | ニューロケム （インターナショナル） リミテッド | β−アミロイド関連疾患の治療のための治療用製剤 |
| KR20050118669A (ko) * | 2003-02-01 | 2005-12-19 | 뉴랄랩 리미티드 | 가용성 ａ-베타에 대한 항체를 생성하기 위한 능동 면역화 |
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| BRPI0417689A8 (pt) * | 2003-12-17 | 2017-04-25 | Elan Pharm Inc | Método para conjugar um imonógeno de peptídeo, composição, conjugado, composição imunogênica, método para induzir uma resposta imune em um indivíduo mamífero, e, uso do conjugado |
| EP1781704A2 (en) * | 2004-07-30 | 2007-05-09 | Rinat Neuroscience Corp. | Antibodies directed against amyloid-beta peptide and methods using same |
| NO346055B1 (no) * | 2005-12-12 | 2022-01-24 | Ac Immune Sa | Antigen konstruksjon, vaksinesammensetning og fremgangsmåte for produksjon derav. |
| PE20090831A1 (es) * | 2007-06-12 | 2009-07-10 | Ac Immune Sa | Anticuerpo monoclonal |
| HUE055739T2 (hu) * | 2009-03-18 | 2021-12-28 | Ac Immune Sa | Eljárás terápiás alkalmazásra |
-
2011
- 2011-09-23 KR KR1020137002631A patent/KR20160005380A/ko active Application Filing
- 2011-09-23 KR KR1020167021791A patent/KR20160099732A/ko active Application Filing
- 2011-09-23 CA CA2811188A patent/CA2811188C/en active Active
- 2011-09-23 KR KR1020197008710A patent/KR102129220B1/ko active IP Right Grant
-
2012
- 2012-09-21 SI SI201231487T patent/SI2758071T1/sl unknown
- 2012-09-21 JP JP2014532040A patent/JP6110861B2/ja active Active
- 2012-09-21 EP EP12772616.4A patent/EP2758071B1/en active Active
- 2012-09-21 SG SG11201400795UA patent/SG11201400795UA/en unknown
- 2012-09-21 ES ES12772616T patent/ES2712951T3/es active Active
- 2012-09-21 BR BR112014006871A patent/BR112014006871A2/pt not_active Application Discontinuation
- 2012-09-21 DK DK12772616.4T patent/DK2758071T3/en active
- 2012-09-21 PL PL12772616T patent/PL2758071T3/pl unknown
- 2012-09-21 CN CN201910160828.6A patent/CN109847058A/zh active Pending
- 2012-09-21 PH PH1/2014/500657A patent/PH12014500657A1/en unknown
- 2012-09-21 CN CN201280057432.5A patent/CN104039346A/zh active Pending
- 2012-09-21 PT PT12772616T patent/PT2758071T/pt unknown
- 2012-09-21 TR TR2019/01846T patent/TR201901846T4/tr unknown
- 2012-09-21 HU HUE12772616A patent/HUE041277T2/hu unknown
- 2012-09-21 AU AU2012312126A patent/AU2012312126B2/en active Active
- 2012-09-21 EA EA201400376A patent/EA032494B1/ru not_active IP Right Cessation
- 2012-09-21 WO PCT/US2012/056728 patent/WO2013044147A1/en active Application Filing
- 2012-09-21 MX MX2014003325A patent/MX350928B/es active IP Right Grant
- 2012-09-21 MY MYPI2014000851A patent/MY169574A/en unknown
-
2014
- 2014-03-18 IL IL231564A patent/IL231564A0/en active IP Right Grant
- 2014-03-20 ZA ZA2014/02071A patent/ZA201402071B/en unknown
-
2023
- 2023-12-22 US US18/395,150 patent/US20240270829A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TR201901846T4 (tr) | 2019-03-21 |
| CN104039346A (zh) | 2014-09-10 |
| CA2811188A1 (en) | 2013-03-23 |
| SG11201400795UA (en) | 2014-10-30 |
| AU2012312126B2 (en) | 2016-11-10 |
| EP2758071B1 (en) | 2018-11-28 |
| SI2758071T1 (sl) | 2019-01-31 |
| ZA201402071B (en) | 2017-08-30 |
| US20240270829A1 (en) | 2024-08-15 |
| KR102129220B1 (ko) | 2020-07-02 |
| EA032494B1 (ru) | 2019-06-28 |
| AU2012312126A1 (en) | 2014-03-27 |
| BR112014006871A2 (pt) | 2017-04-04 |
| MY169574A (en) | 2019-04-22 |
| KR20190035948A (ko) | 2019-04-03 |
| ES2712951T3 (es) | 2019-05-16 |
| CN109847058A (zh) | 2019-06-07 |
| JP6110861B2 (ja) | 2017-04-05 |
| CA2811188C (en) | 2020-04-28 |
| IL231564A0 (en) | 2014-04-30 |
| DK2758071T3 (en) | 2019-02-18 |
| EP2758071A1 (en) | 2014-07-30 |
| MX350928B (es) | 2017-09-26 |
| KR20160005380A (ko) | 2016-01-15 |
| PH12014500657A1 (en) | 2014-05-05 |
| EA201400376A1 (ru) | 2014-09-30 |
| KR20160099732A (ko) | 2016-08-22 |
| PL2758071T3 (pl) | 2019-08-30 |
| WO2013044147A1 (en) | 2013-03-28 |
| PT2758071T (pt) | 2019-01-11 |
| MX2014003325A (es) | 2014-05-21 |
| NZ622653A (en) | 2015-12-24 |
| JP2014531455A (ja) | 2014-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201305897B (en) | Combination therapy | |
| HK1207967A1 (en) | Vaccine | |
| ZA201400120B (en) | Combination therapy | |
| GB201223386D0 (en) | Vaccine | |
| IL231043A0 (en) | vaccine | |
| PL2489413T3 (pl) | Przyrząd terapeutyczny | |
| ZA201502595B (en) | Therapeutic methods | |
| GB201119999D0 (en) | Vaccine | |
| EP2701744A4 (en) | COMBINATION THERAPY | |
| ZA201402071B (en) | Vaccine therapy | |
| GB201207305D0 (en) | Therapy | |
| ZA201306245B (en) | Combination vaccines | |
| RS59568B1 (sr) | Terapeutski tretman | |
| GB201120000D0 (en) | Vaccine | |
| GB201202090D0 (en) | Vaccine | |
| GB201102913D0 (en) | Novel therapeutic | |
| GB201210226D0 (en) | Vaccine | |
| GB201121647D0 (en) | Vaccine | |
| GB201108256D0 (en) | Vaccine | |
| GB201120096D0 (en) | Novel therapy | |
| GB201114226D0 (en) | Combination therapy | |
| GB201107549D0 (en) | Cancer vaccine | |
| GB201110895D0 (en) | Therapeutic use | |
| GB201109294D0 (en) | Novel vaccine | |
| GB201108984D0 (en) | Vaccines |